Healthcare organizations are adopting AI-enabled clinical tools at an accelerating pace.
Boards and executive teams must ensure that governance structures evolve with those tools.
These Governance Briefs are designed to highlight board-level oversight considerations, risk alignment questions,
and accountability frameworks relevant to AI-assisted clinical decision-making.
They are not technical engineering documents.
They are governance memoranda intended to support informed executive discussion.
Board Considerations Before Adopting LLM-Based Clinical Tools:
Governance Brief No.1
A board-level review of oversight structure, validation requirements, accountability allocation, and vendor risk alignment before deployment.
Governance Brief No.2
This brief outlines governance considerations related to liability exposure when AI- or LLM-assisted tools influence clinical decision-making.
Governance Brief No.3
This brief outlines governance considerations related to speech-to-text transcription accuracy in AI-assisted clinical documentation workflows.
Governance Brief No. 4
This brief outlines governance considerations regarding human verification standards for AI- or LLM-assisted tools integrated into clinical workflows.
Governance Brief No.5
This brief outlines governance considerations related to vendor risk allocation, contractual protections, and insurance alignment when adopting AI- or LLM-enabled clinical tools.
Boards evaluating AI-enabled clinical systems may benefit from an independent governance perspective before deployment.
A structured external review often surfaces gaps that are easy to miss during implementation planning.